Search Within

Eduard Reznik

  1. "Population Sciences Research Program"
Formats
  1. Journal Article (18)
  2. Meeting Abstract (5)
Groups
  1. Center for Molecular Imaging and Biotechnology (CMIB) (23)
  2. Computational Oncology Service (23)
  3. Epidemiology and Biostatistics (23)
  4. GSK Faculty (23)
  5. Population Sciences Research Program (23)
  6. Department of Medicine (22)

More Groups

People
  1. Maria Carlo (19)
  2. Abraham Hakimi (17)
  3. Robert Motzer (17)
  4. Martin Voss (15)
  5. Chung-Han Lee (14)
  6. Paul Russo (14)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (2)
  4. 2022 (5)
  5. 2021 (5)
  6. 2020 (2)

More Years

Publications
  1. Journal of Clinical Oncology (4)
  2. Clinical Cancer Research (3)
  3. European Urology Focus (3)
  4. Cell (2)
  5. European Urology (2)
  6. Cancer (1)

More Publications

Publishers
  1. American Association for Cancer Research (4)
  2. American Society of Clinical Oncology (4)
  3. Cell Press (3)
  4. Elsevier B.V. (3)
  5. Elsevier Science, Inc. (2)
  6. Biomed Central Ltd (1)

More Publishers

Results (23)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pan-cancer analysis of biallelic inactivation in tumor suppressor genes identifies KEAP1 zygosity as a predictive biomarker in lung cancer
    Journal Article

    Zucker, M.; Perry, M. A.; Gould, S. I.; Elkrief, A.; Safonov, A.; Thummalapalli, R.; Mehine, M.; Chakravarty, D.; Brannon, A. R.; Ladanyi, M.; more...
    Cell (2025)

    Fulltext@MSK | Save
  • Obesity-dependent selection of driver mutations in cancer
    Journal Article

    Tang, C.; Castillon, V. J.; Waters, M.; Fong, C.; Park, T.; Boscenco, S.; Kim, S.; Pekala, K.; Carrot-Zhang, J.; Hakimi, A. A.; more...
    Nature Genetics (2024)

    Fulltext@MSK | Save
  • Node positive non-clear cell renal cell carcinoma: Oncological outcomes and genomic insights
    Meeting Abstract

    Eismann, L.; Zucker, M.; Dawidek, M.; Reese, S.; Posada Calderon, L.; Aulitzky, A.; Stief, C.; Coleman, J.; Kotecha, R.; Carlo, M.; more...
    European Urology (2024)

    Fulltext@MSK | Save
  • A phase 2 trial of talazoparib and avelumab in genomically defined metastatic kidney cancer
    Journal Article

    Kotecha, R. R.; Doshi, S. D.; Knezevic, A.; Chaim, J.; Chen, Y.; Jacobi, R.; Zucker, M.; Reznik, E.; McHugh, D.; Shah, N. J.; more...
    European Urology Oncology (2024)

    Fulltext@MSK | Save
  • Genomic ancestry in kidney cancer: Correlations with clinical and molecular features
    Journal Article

    Kotecha, R. R.; Knezevic, A.; Arora, K.; Bandlamudi, C.; Kuo, F.; Carlo, M. I.; Fitzgerald, K. N.; Feldman, D. R.; Shah, N. J.; Reznik, E.; more...
    Cancer (2024)

    Fulltext@MSK | Save
  • Nivolumab plus cabozantinib in patients with non-clear cell renal cell carcinoma: Updated results from a phase 2 trial
    Meeting Abstract

    Lee, C. H.; Fitzgerald, K. N.; Voss, M. H.; Carlo, M. I.; Knezevic, A.; Peralta, L.; Chen, Y. B.; Zucker, M.; Lefkowitz, R. A.; Reznik, E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Immunometabolic coevolution defines unique microenvironmental niches in ccRCC
    Journal Article

    Tang, C.; Xie, A. X.; Liu, E. M.; Kuo, F.; Kim, M.; DiNatale, R. G.; Golkaram, M.; Chen, Y. B.; Gupta, S.; Motzer, R. J.; more...
    Cell Metabolism (2023)

    Fulltext@MSK | Save
  • Genomic and metabolic hallmarks of SDH- and FH-deficient renal cell carcinomas
    Journal Article

    Yoo, A.; Tang, C.; Zucker, M.; Fitzgerald, K.; DiNatale, R. G.; Rappold, P. M.; Weiss, K.; Freeman, B.; Lee, C. H.; Schultz, N.; more...
    European Urology Focus (2022)

    Fulltext@MSK | Save
  • Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escape
    Journal Article

    Golkaram, M.; Kuo, F.; Gupta, S.; Carlo, M. I.; Salmans, M. L.; Vijayaraghavan, R.; Tang, C.; Makarov, V.; Rappold, P.; Blum, K. A.; more...
    Genome Medicine (2022)

    Fulltext@MSK | Save
  • Phase II trial of cabozantinib plus nivolumab in patients with non-clear-cell renal cell carcinoma and genomic correlates
    Journal Article

    Lee, C. H.; Voss, M. H.; Carlo, M. I.; Chen, Y. B.; Zucker, M.; Knezevic, A.; Lefkowitz, R. A.; Shapnik, N.; Dadoun, C.; Reznik, E.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save